FINCH THERAPEUTICS
Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs. The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models. Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.
FINCH THERAPEUTICS
Industry:
Biotechnology Clinical Trials Machine Learning Therapeutics
Founded:
2017-01-01
Address:
Somerville, Massachusetts, United States
Country:
United States
Website Url:
http://www.finchtherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
(617) 229-6499
Email Addresses:
[email protected]
Total Funding:
188.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-10-23 | Crestovo | Crestovo acquired by Finch Therapeutics | N/A |
Investors List
Symbiosis Group
Symbiosis Group investment in Series D - Finch Therapeutics
Willett Advisors LLC
Willett Advisors LLC investment in Series D - Finch Therapeutics
MSD Capital
MSD Capital investment in Series D - Finch Therapeutics
Octave Group
Octave Group investment in Series D - Finch Therapeutics
Susquehanna International Group (SIG)
Susquehanna International Group (SIG) investment in Series D - Finch Therapeutics
OMX Ventures
OMX Ventures investment in Series D - Finch Therapeutics
Octave Ventures LLC
Octave Ventures LLC investment in Series D - Finch Therapeutics
MSD Partners
MSD Partners investment in Series D - Finch Therapeutics
Avenir Growth Capital
Avenir Growth Capital investment in Series D - Finch Therapeutics
Humboldt Fund
Humboldt Fund investment in Series D - Finch Therapeutics
Key Employee Changes
Official Site Inspections
http://www.finchtherapeutics.com Semrush global rank: 225.66 K Semrush visits lastest month: 322.22 K
- Host name: 172.67.153.154
- IP address: 172.67.153.154
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
